another-very
Apple wins patent trial against Pendrell subsidiary
November 21, 2015 by publisher · Leave a Comment
By Lisa Bose McDermott MARSHALL, Texas (Reuters) – A U.S. jury on Friday found Apple Inc did not infringe five antipiracy patents owned by a Pendrell Corp subsidiary at trial in a Texas federal court. The jury also found that Apple did not prove that the patents were invalid. An Apple attorney declined to comment.
Continued here:
Apple wins patent trial against Pendrell subsidiary
another-very
VW cuts 2016 capital spending plan as cheating scandal widens
November 21, 2015 by admin · Leave a Comment
By Andreas Cremer and David Shepardson WOLFSBURG, Germany/WASHINGTON (Reuters) – Volkswagen AG cut 1 billion euros ($1.1 billion) from its 2016 investment plan on Friday, as its emissions cheating scandal expanded to include tens of thousands more U.S. vehicles. Volkswagen has told U.S. regulators that emissions issues in larger luxury cars and SUVs extend to…
View original here:
VW cuts 2016 capital spending plan as cheating scandal widens
another-very
Ford union workers ratify new four-year U.S. labor pact: UAW
November 21, 2015 by admin · Leave a Comment
Ford Motor Co's U.S. union workers narrowly approved a four-year labor contract after a late push for support by United Auto Workers leaders, the UAW said late Friday night. The UAW said 51.3 percent of production workers and 52.4 percent of skilled trades workers voted in favor of the new contract, after more than a week of voting that concluded at U.S. operations of Ford on Friday night.
See the original post here:
Ford union workers ratify new four-year U.S. labor pact: UAW
another-very
Exclusive: Pfizer, Allergan CEOs agree on combined company roles – sources
November 21, 2015 by elegant · Leave a Comment
Pfizer Inc and Allergan Inc chief executives have agreed on the roles they would assume in a combined company, removing one of the last hurdles to the largest ever healthcare merger, people familiar with the matter said. Pfizer CEO Ian Read will be CEO of the combined company, while Allergan CEO Brent Saunders will have another very senior role, the people said on Friday, without providing more details. Pfizer and Allergan declined to comment.
Original post:
Exclusive: Pfizer, Allergan CEOs agree on combined company roles – sources